Fatal Adenovirus Infection During Alemtuzumab (Anti-CD52 Monoclonal Antibody) Treatment of a Patient with Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia

This publication has 19 references indexed in Scilit:

• Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)
  Blood, 2002
• Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study
  Blood, 2002
• High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H
  Blood, 2001
• Community respiratory virus infections following lung transplantation
  Transplant Infectious Disease, 2001
• FATAL DISSEMINATED ADENOVIRAL INFECTION IN A RENAL TRANSPLANT PATIENT
  Transplantation, 2001
• Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children
  Bone Marrow Transplantation, 2001
• Adenovirus Infections in Hematopoietic Stem Cell Transplant Recipients
  Clinical Infectious Diseases, 1999
• Humanized CD52 monoclonal antibody campath‐1H as first‐line treatment in chronic lymphocytic leukaemia
  British Journal of Haematology, 1996
• Adenoviruses in the immunocompromised host
  Clinical Microbiology Reviews, 1992
• Adenovirus Infection in Pediatric Liver Transplant Recipients
  The Journal of Infectious Diseases, 1992